Helen S. Mayberg

59.4k total citations · 19 hit papers
304 papers, 36.0k citations indexed

About

Helen S. Mayberg is a scholar working on Cognitive Neuroscience, Neurology and Pharmacology. According to data from OpenAlex, Helen S. Mayberg has authored 304 papers receiving a total of 36.0k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Cognitive Neuroscience, 120 papers in Neurology and 61 papers in Pharmacology. Recurrent topics in Helen S. Mayberg's work include Neurological disorders and treatments (116 papers), Functional Brain Connectivity Studies (107 papers) and Treatment of Major Depression (60 papers). Helen S. Mayberg is often cited by papers focused on Neurological disorders and treatments (116 papers), Functional Brain Connectivity Studies (107 papers) and Treatment of Major Depression (60 papers). Helen S. Mayberg collaborates with scholars based in United States, Canada and Germany. Helen S. Mayberg's co-authors include Sidney H. Kennedy, Paul E. Holtzheimer, Andrés M. Lozano, Paul Jerabek, Clement Hamani, Mario Liotti, Scott McGinnis, R. Cameron Craddock, Kerry J. Ressler and Roderick K. Mahurin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Helen S. Mayberg

292 papers receiving 34.8k citations

Hit Papers

Deep Brain Stimulation for Treatment-Resistant Depression 1997 2026 2006 2016 2005 1999 1997 2011 2012 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Deep Brain Stimulation for Treatment-Resistant Depression
    2005 2.7k citations Helen S. Mayberg, Andrés M. Lozano et al. Neuron profile →
  2. Reciprocal Limbic-Cortical Function and Negative Mood: Converging PET Findings in Depression and Normal Sadness
    1999 1.9k citations Helen S. Mayberg, Stephen K. Brannan et al. American Journal of Psychiatry profile →
  3. Limbic-cortical dysregulation: a proposed model of depression
    1997 1.2k citations Helen S. Mayberg profile →
  4. A whole brain fMRI atlas generated via spatially constrained spectral clustering
    2011 1.1k citations Paul E. Holtzheimer, Helen S. Mayberg et al. Human Brain Mapping profile →
  5. Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
    2012 999 citations Helen S. Mayberg, Charles B. Nemeroff et al. profile →
  6. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment
    2003 894 citations Helen S. Mayberg profile →
  7. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response
    2000 875 citations Helen S. Mayberg et al. profile →
  8. Attending to the present: mindfulness meditation reveals distinct neural modes of self-reference
    2007 837 citations Helen S. Mayberg et al. profile →
  9. Cingulate function in depression
    1997 832 citations Helen S. Mayberg, Stephen K. Brannan et al. profile →
  10. Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity
    2000 800 citations Helen S. Mayberg et al. profile →
  11. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
    2007 780 citations Helen S. Mayberg et al. profile →
  12. Modulation of Cortical-Limbic Pathways in Major Depression
    2004 723 citations Sidney H. Kennedy, Helen S. Mayberg et al. profile →
  13. Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression
    2008 678 citations Andrés M. Lozano, Helen S. Mayberg et al. profile →
  14. Limbic–frontal circuitry in major depression: a path modeling metanalysis
    2004 556 citations Helen S. Mayberg, Sidney H. Kennedy et al. profile →
  15. Changes in Regional Brain Glucose Metabolism Measured With Positron Emission Tomography After Paroxetine Treatment of Major Depression
    2001 552 citations Sidney H. Kennedy, Helen S. Mayberg et al. American Journal of Psychiatry profile →
  16. An ERP study of the temporal course of the Stroop color-word interference effect
    2000 534 citations Helen S. Mayberg et al. profile →
  17. The Functional Neuroanatomy of the Placebo Effect
    2002 514 citations Helen S. Mayberg et al. American Journal of Psychiatry profile →
  18. Neurobiological Mechanisms of the Placebo Effect
    2005 508 citations Helen S. Mayberg et al. profile →
  19. A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression
    2017 298 citations Patricio Riva‐Posse, Ki Sueng Choi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen S. Mayberg United States 88 18.0k 7.7k 6.8k 6.1k 5.7k 304 36.0k
Barbara J. Sahakian United Kingdom 131 28.3k 1.6× 5.7k 0.7× 10.7k 1.6× 12.1k 2.0× 2.6k 0.5× 604 55.3k
Wayne C. Drevets United States 109 19.6k 1.1× 2.2k 0.3× 9.4k 1.4× 10.0k 1.6× 3.2k 0.6× 352 47.0k
Mark S. George United States 103 16.9k 0.9× 5.1k 0.7× 2.8k 0.4× 3.8k 0.6× 20.1k 3.5× 587 35.3k
Scott L. Rauch United States 111 26.4k 1.5× 3.4k 0.4× 11.5k 1.7× 6.7k 1.1× 2.3k 0.4× 348 46.6k
René S. Kahn Netherlands 108 19.3k 1.1× 1.8k 0.2× 5.1k 0.7× 5.1k 0.8× 3.0k 0.5× 734 45.5k
Sylvain Houle Canada 94 10.5k 0.6× 4.0k 0.5× 1.9k 0.3× 8.5k 1.4× 2.3k 0.4× 421 28.1k
Carlo Caltagirone Italy 94 15.8k 0.9× 6.2k 0.8× 3.0k 0.4× 3.8k 0.6× 7.6k 1.3× 900 36.8k
Robert A. Koeppe United States 94 13.1k 0.7× 6.3k 0.8× 2.3k 0.3× 6.2k 1.0× 2.7k 0.5× 385 34.4k
Philip McGuire United Kingdom 123 25.9k 1.4× 3.2k 0.4× 8.9k 1.3× 6.9k 1.1× 2.0k 0.4× 892 56.3k
Simon B. Eickhoff Germany 115 46.4k 2.6× 3.4k 0.4× 11.3k 1.7× 2.9k 0.5× 6.1k 1.1× 699 60.8k

Countries citing papers authored by Helen S. Mayberg

Since Specialization
Citations

This map shows the geographic impact of Helen S. Mayberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen S. Mayberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen S. Mayberg more than expected).

Fields of papers citing papers by Helen S. Mayberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen S. Mayberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen S. Mayberg. The network helps show where Helen S. Mayberg may publish in the future.

Co-authorship network of co-authors of Helen S. Mayberg

This figure shows the co-authorship network connecting the top 25 collaborators of Helen S. Mayberg. A scholar is included among the top collaborators of Helen S. Mayberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen S. Mayberg. Helen S. Mayberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhattacharyya, Sudeepa, Siamak MahmoudianDehkordi, Matthew J. Sniatynski, et al.. (2025). Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder. Journal of Affective Disorders. 375. 397–405. 3 indexed citations
2.
LoParo, Devon, Boadie W. Dunlop, Charles B. Nemeroff, Helen S. Mayberg, & W. Edward Craighead. (2025). Prediction of individual patient outcomes to psychotherapy vs medication for major depression. PubMed. 4(1). 4–4. 4 indexed citations
3.
Paul, Elisabeth, Margareta Östman, Markus Heilig, Helen S. Mayberg, & J. Paul Hamilton. (2023). Towards a multilevel model of major depression: genes, immuno-metabolic function, and cortico-striatal signaling. Translational Psychiatry. 13(1). 171–171. 4 indexed citations
4.
Dunlop, Boadie W., Jungho Cha, Ki Sueng Choi, et al.. (2023). Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence. Neuropsychopharmacology. 48(13). 1901–1909. 10 indexed citations
5.
Brydges, Christopher R., Sudeepa Bhattacharyya, Yuri Milaneschi, et al.. (2022). Metabolomic and inflammatory signatures of symptom dimensions in major depression. Brain Behavior and Immunity. 102. 42–52. 60 indexed citations
6.
Dunlop, Boadie W., et al.. (2022). Assessing in-session rumination and its effects on CBT for depression. Behaviour Research and Therapy. 159. 104209–104209. 5 indexed citations
7.
Jiang, Zifan, Sahar Harati, Andrea Crowell, et al.. (2020). Classifying Major Depressive Disorder and Response to Deep Brain Stimulation Over Time by Analyzing Facial Expressions. IEEE Transactions on Biomedical Engineering. 68(2). 664–672. 34 indexed citations
8.
Harati, Sahar, Andrea Crowell, Yijian Huang, Helen S. Mayberg, & Shamim Nemati. (2019). Classifying Depression Severity in Recovery From Major Depressive Disorder via Dynamic Facial Features. IEEE Journal of Biomedical and Health Informatics. 24(3). 815–824. 22 indexed citations
9.
Higgins, Ixavier A., Suprateek Kundu, Ki Sueng Choi, Helen S. Mayberg, & Ying Guo. (2019). A difference degree test for comparing brain networks. Human Brain Mapping. 40(15). 4518–4536. 16 indexed citations
10.
Dunlop, Boadie W., Devon LoParo, Becky Kinkead, et al.. (2019). Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression. American Journal of Psychiatry. 176(4). 275–286. 38 indexed citations
11.
Ahmed, Ahmed T., Mark A. Frye, A. John Rush, et al.. (2018). Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. Journal of Affective Disorders. 238. 1–7. 18 indexed citations
12.
Dunlop, Boadie W., et al.. (2018). Follow-up of monotherapy remitters in the PReDICT study: Maintenance treatment outcomes and clinical predictors of recurrence.. Journal of Consulting and Clinical Psychology. 86(2). 189–199. 14 indexed citations
13.
Syed, Shariful A., Eléonore Beurel, David Loewenstein, et al.. (2018). Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response. Neuron. 99(5). 914–924.e3. 165 indexed citations
14.
Choi, Ki Sueng, Patricio Riva‐Posse, Robert E. Gross, & Helen S. Mayberg. (2015). Mapping the “Depression Switch” During Intraoperative Testing of Subcallosal Cingulate Deep Brain Stimulation. JAMA Neurology. 72(11). 1252–1252. 92 indexed citations
15.
Filkowski, Megan M., Helen S. Mayberg, & Paul E. Holtzheimer. (2015). Considering Eligibility for Studies of Deep Brain Stimulation for Treatment-Resistant Depression. Journal of Ect. 32(2). 122–126. 9 indexed citations
16.
Luján, J. Luis, Ashutosh Chaturvedi, Ki Sueng Choi, et al.. (2013). Tractography-Activation Models Applied to Subcallosal Cingulate Deep Brain Stimulation. Brain stimulation. 6(5). 737–739. 72 indexed citations
17.
Kelley, Mary E., Alexandre R. Franco, Helen S. Mayberg, & Paul E. Holtzheimer. (2012). The Illness Density Index (IDI): A longitudinal measure of treatment efficacy. Clinical Trials. 9(5). 596–604. 8 indexed citations
18.
Kennedy, Sidney H., Peter Giacobbe, Sakina J. Rizvi, et al.. (2011). Deep Brain Stimulation for Treatment-Resistant Depression: Follow-Up After 3 to 6 Years. American Journal of Psychiatry. 168(5). 502–510. 333 indexed citations
19.
Holtzheimer, Paul E. & Helen S. Mayberg. (2010). Deep Brain Stimulation for Treatment-Resistant Depression. American Journal of Psychiatry. 167(12). 1437–1444. 62 indexed citations
20.
Nemeroff, Charles B., Helen S. Mayberg, Scott E. Krahl, et al.. (2006). VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms. Neuropsychopharmacology. 31(7). 1345–1355. 335 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara J. Sahakian Breakdown of academic impact, for papers by Wayne C. Drevets Breakdown of academic impact, for papers by Mark S. George Breakdown of academic impact, for papers by Scott L. Rauch Breakdown of academic impact, for papers by René S. Kahn Breakdown of academic impact, for papers by Sylvain Houle Breakdown of academic impact, for papers by Carlo Caltagirone Breakdown of academic impact, for papers by Robert A. Koeppe Breakdown of academic impact, for papers by Philip McGuire Breakdown of academic impact, for papers by Simon B. Eickhoff
Rankless by CCL
2026